pcca semaglutide Injectables for Weight Loss Management Semaglutide in Corpus Christi |

After completing dose titration over 16 weeks, patients transition to a once-weekly 2.4mg injection for ongoing weight maintenance

For many patients, this represents a substantial reduction from current cash pay pricing for GLP-1 medications

The pipeline of next-generation treatments is advancing rapidly: Novo Nordisks CagriSema, a fixed-dose combination of semaglutide and the amylin analogue cagrilintide, has an FDA decision expected in late 2026 and could further accelerate the market

[1] Understanding the relationship between milligrams (mg) and injection units is essential for safe and effective administration